Literature DB >> 27620619

High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren's syndrome.

Jayakanthan Kabeerdoss1, Pulukool Sandhya2, Santosh Kumar Mandal2, Mahasampath Gowri3, Debashish Danda2.   

Abstract

In present study, we aimed to study salivary soluble L-selectin (sL-selectin), interleukin-7(IjL-7), and lymphotoxin-α levels in primary Sjögren's syndrome (pSS) and their clinical as well as serological correlations. pSS patients fulfilling either the American European Consensus Group (AECG) and/or the American college of Rheumatology (ACR) criteria were recruited. Age- and sex-matched hospital staff were recruited as healthy controls. Unstimulated saliva was collected by the spitting method; sL-selectin, IL-7, and lymphotoxin-α were measured in the saliva using commercial ELISA kits. Forty-three patients with pSS and 31 healthy controls were included in the study. Increased levels of sL-selectin and IL-7 were found in the saliva of patients as compared to controls. Lymphotoxin-α was undetectable in the saliva of pSS patients and controls. Salivary sL-selectin positively correlated with rheumatoid factor (r = 0.47; p < 0.003). No other variable including ESSDAI was significantly associated with salivary sL-selectin and IL-7 levels. Indian patients with primary Sjögren's syndrome have higher salivary sL-selectin and IL-7 levels than healthy controls.

Entities:  

Keywords:  Interleukin-7; Lymphotoxin-α; Saliva; Sjögren’s syndrome; Soluble L-selectin

Mesh:

Substances:

Year:  2016        PMID: 27620619     DOI: 10.1007/s10067-016-3406-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Authors:  S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

3.  Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Authors:  Teresa Greenwell-Wild; Niki M Moutsopoulos; Maria Gliozzi; Efstathia Kapsogeorgou; Zoila Rangel; Peter J Munson; Haralampos M Moutsopoulos; Sharon M Wahl
Journal:  Arthritis Rheum       Date:  2011-10

4.  Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.

Authors:  M García-Carrasco; P Pizcueta; R Cervera; M Ramos-Casals; A Sisó; G de La Red; M Ingelmo; J Font; P Engel
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

5.  Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction.

Authors:  Angela Bikker; C Erik Hack; Floris P J G Lafeber; Joel A G van Roon
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Expression of selectins (CD62 E,L,P) and cellular adhesion molecules in primary Sjögren's syndrome: questions to immunoregulation.

Authors:  K E Aziz; P J McCluskey; D Wakefield
Journal:  Clin Immunol Immunopathol       Date:  1996-07

7.  A role for lymphotoxin in primary Sjogren's disease.

Authors:  Long Shen; Lakshmanan Suresh; Jing Wu; Jingxiu Xuan; Hong Li; Chongjie Zhang; Oleh Pankewycz; Julian L Ambrus
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

8.  IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome.

Authors:  J V Dunne; D A Carson; H L Spiegelberg; M A Alspaugh; J H Vaughan
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

9.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

10.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Authors:  Richard J Bende; Wilhelmina M Aarts; Robert G Riedl; Daphne de Jong; Steven T Pals; Carel J M van Noesel
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more
  2 in total

1.  CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.

Authors:  Santosh Kumar Mandal; Pulukool Sandhya; Jayakanthan Kabeerdoss; Janardana Ramya; Gowri Mahasampath; Debashish Danda
Journal:  Rheumatol Int       Date:  2018-03-14       Impact factor: 2.631

Review 2.  Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review.

Authors:  Ju-Yang Jung; Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.